Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines.

Trial Profile

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Meningococcal vaccine group C conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Hib-DTaP-poliovirus vaccine; Hib-meningococcal vaccine group C conjugate
  • Indications Meningococcal group C infections; Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Mar 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 27 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2010 Results published in the Pediatric Infectious Disease Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top